Quick Summary
- Unabsorbed free Fe²⁺ in the colon may catalyse Fenton reactions, generating hydroxyl radicals.
- These radicals are associated with damage to the colonic mucosal barrier and disruption of the gut microbiome.
- In fortification studies, Lactobacillus populations decreased while enterobacteria proliferated.
- Chelated iron forms (bisglycinate) reduce free iron reaching the colon, potentially reducing constipation.
Quick Answer: It's About Unabsorbed Iron, Not Iron Itself
Iron pills cause constipation when a large fraction of the ingested dose passes through the small intestine unabsorbed and reaches the colon as free Fe²⁺ ions. There, Fe²⁺ may catalyse the Fenton reaction (Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻), generating hydroxyl radicals that are associated with mucosal damage. Clinical trials (Tolkien et al., 2015) associate ferrous sulfate with significantly increased GI side effects including constipation.
The critical variable is how much iron reaches the colon, which depends on the iron form, dose — specifically elemental iron vs compound weight — and absorption pathway.
What's Actually Happening Inside Your Gut?
When you swallow an iron tablet, most of it doesn't get absorbed in the small intestine — it keeps travelling until it reaches your colon, where it causes irritation. Research suggests this is associated with slowed colonic transit — here's how that process is understood to work:
Step 1: The Small Intestine Can Only Absorb So Much
Non-chelated iron salts (ferrous sulfate, fumarate, gluconate) release free Fe²⁺ ions in the acidic stomach environment. These ions are absorbed in the duodenum via the DMT1 (divalent metal transporter 1). But DMT1 has a saturation ceiling — it can only transport a limited amount of Fe²⁺ per dose window.
At a standard 65 mg elemental iron dose (from 200 mg ferrous sulfate), DMT1 absorbs roughly 7–8 mg. The remaining ~57–58 mg passes unabsorbed into the jejunum, ileum, and ultimately the colon.
Step 2: Unabsorbed Iron Irritates Your Colon
The iron that wasn't absorbed reacts with natural compounds in your colon and may produce highly reactive chemicals that can damage the gut lining. Once free Fe²⁺ reaches the colon, it encounters hydrogen peroxide (H₂O₂) — a normal byproduct of aerobic bacterial metabolism. In an animal model, Carrier et al. (2001) showed that oral iron increased colonic oxidative stress and worsened experimental colitis in rats — consistent with Fenton-mediated damage. Tolkien et al. (2015), in a meta-analysis of 43 human trials, confirmed that ferrous sulfate significantly increases GI side effects including constipation. The Fenton reaction generates hydroxyl radicals (OH•), one of the most reactive oxygen species in biology:
Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻
These radicals are associated with damage to the colonic mucosal lining — injuring epithelial cells, disrupting the mucus barrier, and contributing to local inflammation.
Step 3: The Colon's Response to Oxidative Damage
In response to oxidative mucosal damage, research suggests the colon slows peristalsis (the rhythmic contractions that move stool forward) and increases water reabsorption. Carrier et al. (2001) showed in a rat colitis model that oral iron significantly increased colonic lipid peroxidation and worsened mucosal inflammation in a dose-dependent manner. The link between colonic oxidative damage and slowed human transit is plausible but not fully established — direct transit-time measurements in humans taking oral iron are limited. The clinical association observed in trials (Tolkien et al., 2015): significantly increased GI side effects including constipation.
The Numbers: How Much Iron Actually Reaches Your Colon?
The type of iron supplement you take determines how much iron reaches your colon — and therefore how much irritation you get. Here's why the numbers are so different between iron forms:
| Parameter | Ferrous Sulfate | Ferrous Bisglycinate |
|---|---|---|
| Iron compound per dose | 200 mg | 130 mg |
| Elemental iron per dose | 65 mg | 36 mg |
| Fractional absorption | ~10–12% | 2–4× higher (food studies; est.) |
| Iron absorbed | ~7–8 mg | Higher per mg |
| Iron reaching colon | ~57–58 mg | Substantially less |
| Absorption pathway | DMT1 | DMT1 (+ proposed PepT1) |
The key insight: ferrous bisglycinate delivers more absorbed iron per milligram while sending substantially less unabsorbed iron to the colon. In fortified-food absorption studies, bisglycinate showed 2–4× higher fractional absorption than ferrous sulfate (Layrisse et al., 2000; Bovell-Benjamin et al., 2000); the ratio in therapeutic supplement doses may differ but the direction is consistent. The exact absorption pathway is still being investigated — in vitro data suggest the PepT1 peptide transporter may also contribute, but this has not been confirmed in vivo.
Excess Iron Also Disrupts Your Gut Bacteria
Beyond direct chemical damage, excess colonic iron may also disrupt the gut microbiome — an effect documented mainly in iron fortification studies in children, and whose contribution to constipation from iron supplements in adults is plausible but not yet directly established.
Zimmermann et al. (2010) showed in a controlled trial of iron-fortified food in African children (aged 6–14) that iron fortification significantly altered the colonic microbiome:
- Enterobacteriaceae (including potentially pathogenic strains such as E. coli) increased significantly
- Protective Lactobacillus populations decreased
- Faecal calprotectin (an inflammation marker) increased, indicating subclinical colonic inflammation
This is relevant to gut function because beneficial gut bacteria produce short-chain fatty acids (SCFAs) that help regulate colonic motility and water balance. When protective species decline and potentially pathogenic bacteria increase, reduced SCFA production could plausibly affect colonic motility — though direct evidence linking iron-induced dysbiosis to constipation in adults remains limited.
The practical implication: reducing the colonic iron load (by choosing a form with higher fractional absorption) may protect both the mucosal lining and the microbiome.
Why Timing and Dose Splitting Don't Fully Solve It
Stoffel et al. (2017) showed that a single iron dose triggers a hepcidin increase that reduces absorption of a subsequent dose — alternate-day dosing achieved higher fractional absorption (21.8% vs 16.3%) than consecutive-day dosing. This has led to alternate-day dosing protocols.
However, alternate-day dosing only modestly improves fractional absorption — it does not eliminate the fundamental problem: non-chelated forms still saturate DMT1 per dose, and most of the unabsorbed remainder still reaches the colon. Alternate-day dosing with ferrous sulfate reduces the frequency of colonic iron exposure but only slightly reduces the per-dose colonic burden (from ~50 mg to ~47 mg unabsorbed, based on the absorption difference).
The more effective strategy is choosing a form with higher fractional absorption, so less iron reaches the colon in the first place.
If Constipation Is Your Main Barrier to Continuing Iron
If constipation has been the reason you stopped or reduced your iron supplement, the evidence points to two actionable steps:
- Discuss with your doctor whether switching to a chelated iron form (lower colonic burden) could resolve the symptom
- Evaluate iron supplements that use ferrous bisglycinate — which achieves higher fractional absorption at lower doses, reducing the colonic iron load
In that context, Hemascore (36 mg elemental iron from ferrous bisglycinate, with Vitamin C, active B12, and active folate) is one formulation designed to reduce the colonic iron load associated with iron-induced constipation.